Medical device companies often assume they have one audience. They don’t. I’ve worked with companies that have three: the clinician, the procurement committee, and the end customer. Each one is evaluating you differently, and I’ve watched brand positioning fall apart when a company tries to say one thing and have it land the same way with all three.
If I had to sum up what marketing requires in one word, it would be clarity. When people can see clearly who you are, what you stand for and what your brand means, they can opt in or opt out easily. That’s a good thing. It’s how trust gets built.
What I see far more often is confusion. And confusion is the enemy of results. People don’t know what you’re offering or who you’re offering it to, so they freeze. They’re already making complex decisions under pressure, and they’re being barraged with marketing messages all day, online and offline. If you don’t say precisely the thing your audience wants to hear, which also means saying something that other audiences don’t want to hear, your brand has no magnetism. It just blends into the noise.
Brand architecture is the first decision, not the last
Before you touch messaging, you need to decide how your brands relate to each other. There are two polar ends of the spectrum, and most companies sit somewhere between them without ever deciding to.
At one end is the branded house. GE is the classic example. Same logo, same name, division tacked on the end: GE Aerospace, GE Healthcare. The advantage is that brand awareness compounds across every division. You’re not starting from zero each time, and it saves real money on marketing. The risk is that two very different businesses sharing a name can confuse people trying to work out how they relate. And if reputational damage hits one division, it tends to splash onto the others.
At the other end is the house of brands. EssilorLuxottica, the Italian eyewear company, runs this model hard. In Australia, they own OPSM, EyeQ and Sunglass Hut, completely distinct in the market, with no obvious connection unless you already know the parent company. They also own Ray-Ban outright and hold a licensing agreement with Ferrari. Over 150 brands sit under that umbrella. Each one can speak with total clarity to its own customer, unencumbered by anyone else’s story. The cost is that every brand has to be built from scratch. That takes time and money, and you’re paying that cost repeatedly.
Most real-world approaches are hybrids. Marriott runs JW Marriott and Courtyard by Marriott under the house name, while Sheraton sits separately. Google uses sub-brands: same parent lending credibility, but distinct logos and identities creating separation where it’s needed. None of this is a template you can lift and drop into your business. It has to be adjusted to your circumstance, your risk profile and what you’re actually trying to communicate to whom.
Why generic B2B branding doesn’t transfer to MedTech
MedTech is its own industry, and it doesn’t play by the same rules as most B2B categories. The sales cycle can be long. The stakes are genuinely high, because people’s lives are on the line in a clinical sense. There are regulatory hurdles most B2B marketers never have to think about.
And then there’s the buying committee itself. In plenty of organisations, that committee is a mixture of clinicians and procurement people sitting in the same room, evaluating the same proposal for entirely different reasons. You need to talk to both. Not with one message stretched to cover everyone, but with a strategy that connects the dots between two different sets of concerns.
What clinicians are actually evaluating
Clinicians don’t want to be sold to. They want evidence. They’re looking for clinical evidence, peer usage, and a clear picture of how the device integrates into their existing workflow. They’re assessing whether your company genuinely understands the clinical environment, not just the device sitting inside it. And everything you say to them sits inside a legal and regulatory framework that constrains what you’re allowed to claim in the first place.
What procurement committees are actually evaluating
Procurement is a different animal entirely. They’re looking for trust signals around risk and compliance documentation, total cost of ownership, vendor stability, and support and training infrastructure. This is a rational, risk-averse buyer. They’re not thinking through your device clinically, and they’re not evaluating it emotionally. What you need to demonstrate here is operational maturity. Can they trust you as a vendor for the long haul, not just trust the device on the table?
Can one brand transmit both?
Yes, but only with the right architecture behind it, and it depends entirely on your business. This is where you apply a strategic framework that pulls together three things: what’s genuinely unique about your company, what your customers actually need, and what your competitors are already saying. You’re looking for the gap in the Venn diagram of those three circles, the space where you can say something unique to your audience.
Sometimes that means saying two different things to two different people. Sometimes it means saying two similar things, framed differently. Either way, it’s a deliberate choice, not an accident of trying to write one piece of content that tries to satisfy everyone and ends up satisfying no one.
Getting practical
Here’s what this looks like once you move past the strategy and into execution.
Write thought leadership content and change hats depending on who you’re writing for. A piece written for procurement should answer procurement’s actual questions: cost, risk, compliance, support. A completely separate piece can talk to the clinician and answer theirs: evidence, workflow integration, clinical understanding. You can do the same again for the end customer if you have one in the mix.
Case studies can be built to speak to more than one audience within the same piece, but this is where the confusion risk creeps back in if you’re not careful. It’s entirely possible to have a champion inside the purchasing group who you can talk to directly, without needing to tick every box for everyone else at the table. Know who you’re writing for in that specific piece of content, and write for them.
The companies winning in MedTech
They’re not the ones shouting the loudest or being the most salesy. They’re the ones who’ve taken the time to rigorously think through what each side of the table actually needs to hear, and who communicate it with clarity.
That’s the keyword again. Clarity. Consistent, clear communication, to the right people, at the right time, with the right message.
